Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist MDMB-CHMICA

Clinical Toxicology - United Kingdom
doi 10.1080/15563650.2016.1186805
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Synergistic Antinociception by the Cannabinoid Receptor Agonist Anandamide and the PPAR-α Receptor Agonist GW7647

European Journal of Pharmacology
Pharmacology
2007English

Radioligand Thermostability Assessment of Agonist-Bound Human Type 2 Cannabinoid Receptor

Biophysical Journal
Biophysics
2019English

Prejunctional and Peripheral Effects of the Cannabinoid CB1 Receptor Inverse Agonist Rimonabant (SR 141716)

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2008English

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants

PLoS ONE
Multidisciplinary
2012English

Synthetic Cannabinoid Receptor Agonists Inhibit Tumor Growth and Metastasis of Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Human Phase I Metabolism of the Novel Synthetic Cannabinoid 5f-Cumyl-Pegaclone

Forensic Toxicology
BiochemistryForensic MedicinePathologyToxicology
2018English

Clinical and Genetic Findings of Turkish Hypophosphatasia Cases

JCRPE Journal of Clinical Research in Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2017English

O-1057, a Potent Water-Soluble Cannabinoid Receptor Agonist With Antinociceptive Properties

British Journal of Pharmacology
Pharmacology
2000English

Cannabinoid Receptor Type 2 Agonist JWH-133 Deteriorates the Liver Toxicity Induced by Cypermethrin

Turkish Journal of Veterinary and Animal Sciences
Veterinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy